依帕列净是格列沙星类药物,在2014的成人中被批准用于治疗2型糖尿病。

清空选项
189628-37-3

BD26181189628-37-398%

¥86.0010g

86087-23-2

BD4042786087-23-297+%

¥30.001g

915095-87-3

BD448059915095-87-397%

¥762.0010g

333361-49-2

BD261810333361-49-295+%

¥2807.001g

915095-94-2

BD289521915095-94-297%

¥89.00250mg

90-80-2

BD12323890-80-298%

¥228.00500g

915095-86-2

BD290567915095-86-297%

¥898.0025g

1